SCHEMBL7557552

SCHEMBL7557552

CCOC(=O)Nc1ccc(OC)cc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
ALDH1A1 P00352 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.55
KCNQ2 O43526 2/20 0.54
KCNQ3 O43525 1/20 0.54
KCNQ4 P56696 1/20 0.54
KCNQ5 Q9NR82 1/20 0.54
MTNR1B P49286 2/20 0.51
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
TSHR P16473 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KMT2A Q03164 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
MTNR1A P48039 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11302948 0.90 CYP1A2 (0.58) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL14097681 0.88 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL2090279 0.87 CYP1A2 (0.58) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL5090952 0.86 NPC1 (0.56) ALDH1A1SMN1; SMN2KCNQ2KCNQ3KCNQ4
SCHEMBL11451154 0.83 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL978331 0.83 GAA (0.49) CYP1A2ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL3106570 0.83 KCNQ3 (0.67) CYP1A2CYP2C9CYP2C19ALDH1A1KCNQ2
SCHEMBL30794991 0.83 KCNQ3 (0.67) CYP1A2CYP2C9CYP2C19ALDH1A1KCNQ2
SCHEMBL11140800 0.81 HPGD (0.51) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL7410024 0.81 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218352-A1 BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) 2002-07-03 EP disclosed
US-6281218-B1 USEFUL IN THE TREATMENT OF CNS DISORDERS. INGELHEIM ITALIA S.P.A. (IT) 2001-08-28 US disclosed
WO-2001021593-A1 NEW BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA S.P.A. (IT) 2001-03-29 WO disclosed